Iman Washington, MD

Cancer Focus:
Breast Cancer

Dr. Iman Washington is an Assistant Member in the Department of Radiation Oncology. She is a member of the Breast section in Radiation Oncology and the Moffitt Breast Program. Dr. Washington received her MD from Duke University School of Medicine, and completed a Preliminary Medicine Residency at Northwestern University/McGraw Medical Center in Chicago. Dr. Washington recently completed a Radiation Oncology Residency at The Ohio State University Wexner Medical Center In Columbus. Her clinical interests include early and locally advanced breast cancer, metastatic breast cancer, and techniques aimed at minimizing radiation-related normal tissue complications. Dr. Washington’s research interests include investigating factors that influence clinical and patient-reported breast cancer outcomes, improving cancer care for underserved populations, and applying new strategies to reduce the late effects of treatment for patients with breast cancer.

 

Education & Training

Residency:

• Northwestern University/McGraw Medical Center - Medicine
• The Ohio State University Wexner Medical Center - Radiation Oncology

Medical School:

• Duke University School of Medicine - MD

Clinical Trial 20030
TAILOR RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive and T3N0 Positive Breast Cancer
Condition: Breast
Intervention: Not Applicable ()
Status: Open

If you believe you are eligible for one of these trials or studies, please call
813-745-6100 or toll-free 1-800-679-0775.

• Jimenez RB, Abdou Y, Anderson P, Barry P, Bradfield L, Bradley JA, Heras LD, Khan A, Matsen C, Rabinovitch R, Reyna C, Salerno KE, Schellhorn SE, Schofield D, Taparra K, Washington I, Wright JL, Zeidan YH, Zellars RC, Horst KC. Postmastectomy Radiation Therapy: An ASTRO/ASCO/SSO Clinical Practice Guideline. Ann Surg Oncol. 2025 Sep. Pubmedid: 40956531.
• Arabzadeh M, Tang YH, Colin-Leitzinger C, Marzban S, Walgenbach D, Morganti S, Mahaganapathy V, Harper E, Teng M, Kresovich JK, Washington I, Parsons HA, Garber JE, West J, Ganesan S, Khiabanian H, Gillis N. Clonal Hematopoiesis Dynamics and Evolutionary Fitness During Cancer Treatment Impact Clinical Outcomes. medRxiv. 2025 Sep. Pubmedid: 40950448. Pmcid: PMC12424905.
• Jimenez RB, Abdou Y, Anderson P, Barry P, Bradfield L, Bradley JA, Heras LD, Khan A, Matsen C, Rabinovitch R, Reyna C, Salerno KE, Schellhorn SE, Schofield D, Taparra K, Washington I, Wright JL, Zeidan YH, Zellars RC, Horst KC. Postmastectomy Radiation Therapy: An ASTRO-ASCO-SSO Clinical Practice Guideline. J Clin Oncol. 2025 Oct.43(30):3292-3311. Pubmedid: 40955654.
• Jimenez RB, Abdou Y, Anderson P, Barry P, Bradfield L, Bradley JA, Heras LD, Khan A, Matsen C, Rabinovitch R, Reyna C, Salerno KE, Schellhorn SE, Schofield D, Taparra K, Washington I, Wright JL, Zeidan YH, Zellars RC, Horst KC. Postmastectomy Radiation Therapy: An ASTRO/ASCO/SSO Clinical Practice Guideline. Pract Radiat Oncol. 2025 Nov.15(6):549-571. Pubmedid: 40956255.
• Ahmed KA, Kim Y, Armaghani AJ, Arrington JA, Costa RL, Czerniecki BJ, Diaz R, Dowell RA, Extermann M, Forsyth PA, Lee KT, Loftus L, Mills MN, Phuoc VH, Rosa M, Soliman HH, Sam CS, Washington IR, Soyano AE, Han HS. Phase II trial of brain MRI surveillance in stage IV breast cancer. Neurooncol. 2025 Jul.27(6):1550-1558. Pubmedid: 39851040. Pmcid: PMC12309701.
• Decker S, Andreozzi J, Hernandez D, Alexander DA, Wickramasinghe V, Hachadorian R, Oraiqat I, Chen E, Washington I, Gui J, Zhang R, Jarvis LA, Bruza P, Gladstone D, Pogue BW. Improving Cherenkov-based radiotherapy dose estimates in diverse patient populations via skin luminance imaging. Phys Med Biol. 2025 Jul.70(15). Pubmedid: 40628285.
• Washington I, Palm RF, White J, Rosenberg SA, Ataya D. The Role of MRI in Breast Cancer and Breast Conservation Therapy. Cancers (Basel). 2024 Jun.16(11). Pubmedid: 38893241. Pmcid: PMC11171236.
• Liveringhouse CL, Mills MN, Ahmed KA, Washington IR, Lee MC, Khakpour N, Laronga C, Czerniecki B, Soliman H, Weinfurtner RJ, Rosa M, Kim Y, Stringfield O, Abdalah M, Diaz R, Montejo M. Phase 2 Study of Preoperative SABR for Early-Stage Breast Cancer: Introduction of a Novel Form of Accelerated Partial Breast Radiation Therapy. Int J Radiat Oncol Biol Phys. 2023 Jul.116(3):611-616. Pubmedid: 36796498.
• Weinfurtner RJ, Abdalah M, Stringfield O, Ataya D, Williams A, Mooney B, Rosa M, Lee MC, Khakpour N, Laronga C, Czerniecki B, Diaz R, Ahmed K, Washington I, Latifi K, Niell B, Montejo M, Raghunand N. Quantitative Changes in Intratumoral Habitats on MRI Correlate With Pathologic Response in Early-stage ER/PR+ HER2− Breast Cancer Treated With Preoperative Stereotactic Ablative Body Radiotherapy. J Breast Imaging. 2022 May.4(3):273-284. Pubmedid: 36686407. Pmcid: PMC9851176.
• Mills MN, Potluri TK, Kawahara Y, Fahey M, Figura NB, Soyano AE, Washington IR, Diaz R, Oliver DE, Yu HM, Etame AB, Vogelbaum MA, Czerniecki BJ, Arrington JA, Sahebjam S, Forsyth PA, Soliman HH, Han HS, Ahmed KA. The presentation of brain metastases in melanoma, non-small cell lung cancer, and breast cancer and potential implications for screening brain MRIs. Breast Cancer Res Treat. 2022 Jan.191(1):209-217. Pubmedid: 34669082.
• Siedow M, Eisner M, Yaney A, Washington I, Zynger D, Martin D, Mo X, Diconstanzo D, Diaz DA. Impact of prostate biopsy secondary pathology review on radiotherapy management. Prostate. 2022 Feb.82(2):210-215. Pubmedid: 34698410.
• Weinfurtner RJ, Raghunand N, Stringfield O, Abdalah M, Niell BL, Ataya D, Williams A, Mooney B, Rosa M, Lee MC, Khakpour N, Laronga C, Czerniecki B, Diaz R, Ahmed K, Washington I, Montejo M. MRI Response to Pre-operative Stereotactic Ablative Body Radiotherapy (SABR) in Early Stage ER/PR+ HER2- Breast Cancer correlates with Surgical Pathology Tumor Bed Cellularity. Clin Breast Cancer. 2022 Feb.22(2):e214-e223. Pubmedid: 34384695.
• Mills M, Liveringhouse C, Lee F, Nanda RH, Ahmed KA, Washington IR, Thapa R, Fridley BL, Blumencranz P, Extermann M, Loftus L, Balducci L, Diaz R. The prevalence of luminal B subtype is higher in older postmenopausal women with ER+/HER2- breast cancer and is associated with inferior outcomes. Geriatr Oncol. 2021 Mar.12(2):219-226. Pubmedid: 32859560. Pmcid: PMC7907245.
• Liveringhouse CL, Washington IR, Diaz R, Jimenez RB, Harris EE, Rabinovitch R, Woodward WA, Torres-Roca JF, Ahmed KA. Genomically Guided Breast Radiation Therapy: A Review of the Current Data and Future Directions. Adv Radiat Oncol. 2021 Jul.6(4):100731. Pubmedid: 34409215. Pmcid: PMC8361058.
• Eckstein JM, Nolan N, Healy E, Wright CL, Jain A, Barney CL, Washington I, McElroy JP, Grecula JC, Wobb JL, Mitchell DL, Miller E, Gamez M, Blakaj D, Diavolitsis V, Bhatt A. Primary vs nodal site PET/CT response as a prognostic marker in oropharyngeal squamous cell carcinoma treated with intensity-modulated radiation therapy. Head Neck. 2020 Sep.42(9):2405-2413. Pubmedid: 32391626.
• Sim AJ, Palm RF, DeLozier KB, Feygelman V, Latifi K, Redler G, Washington IR, Wuthrick EJ, Rosenberg SA. MR-guided stereotactic body radiation therapy for intracardiac and pericardial metastases. Clin Transl Radiat Oncol. 2020 Nov.25:102-106. Pubmedid: 33204858. Pmcid: PMC7653008.
• Figura NB, Rizk VT, Mohammadi H, Evernden B, Mokhtari S, Yu HM, Robinson TJ, Etame AB, Tran ND, Liu J, Washington I, Diaz R, Czerniecki BJ, Soliman H, Han HS, Sahebjam S, Forsyth PA, Ahmed KA. Clinical outcomes of breast leptomeningeal disease treated with intrathecal trastuzumab, intrathecal chemotherapy, or whole brain radiation therapy. Breast Cancer Res Treat. 2019 Jun.175(3):781-788. Pubmedid: 30859348.
• Ahmed KA, Liveringhouse CL, Mills MN, Figura NB, Grass GD, Washington IR, Harris EE, Czerniecki BJ, Blumencranz PW, Eschrich SA, Scott JG, Diaz R, Torres-Roca JF. Utilizing the genomically adjusted radiation dose (GARD) to personalize adjuvant radiotherapy in triple negative breast cancer management. EBioMedicine. 2019 Aug.47:163-169. Pubmedid: 31416721. Pmcid: PMC6796536.
• Wright CL, Washington IR, Bhatt AD, Knopp MV. Emerging Opportunities for Digital PET/CT to Advance Locoregional Therapy in Head and Neck Cancer. Semin Radiat Oncol. 2019 Apr.29(2):93-101. Pubmedid: 30827458.
• Washington I, Chino JP, Marks LB, D'Amico TA, Berry MF, Ready NE, Higgins KA, Yoo DS, Kelsey CR. Diabetes mellitus: A significant co-morbidity in the setting of lung cancer?. Thorac Cancer. 2013 May.4(2):123-130. Pubmedid: 28920196.
• Lee CL, Moding EJ, Cuneo KC, Li Y, Sullivan JM, Mao L, Washington I, Jeffords LB, Rodrigues RC, Ma Y, Das S, Kontos CD, Kim Y, Rockman HA, Kirsch DG. p53 functions in endothelial cells to prevent radiation-induced myocardial injury in mice. Sci Signal. 2012 Jul.5(234):ra52. Pubmedid: 22827996. Pmcid: PMC3533440.